Found 11 matching trials
Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)
PHASE1This study will evaluate the safety, tolerability, and effect of multiple d...
Location
Multiple Locations
Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)
PHASE3This is a multicenter study to test the hypothesis that suvorexant (MK-4305...
Location
Multiple Locations
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
PHASE4Investigators propose a double-blind, placebo-controlled trial evaluating t...
Location
MUSC Department of Family Medicine
Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)
PHASE3This is a multicenter study to test the hypothesis that suvorexant (MK-4305...
Location
Multiple Locations
Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users
PHASE1This placebo- and active controlled study will investigate the abuse potent...
Location
Altasciences Clinical Kansas, Inc. (former Vince and Associates Clinical Research, Inc.)
Efficacy and Safety of Suvorexant (MK-4305) for Reducing Incidence of Delirium in Japanese Participants at High Risk of Delirium (MK-4305-085)
PHASE3The goal of this study is to evaluate the efficacy and safety of suvorexant...
Location
Kohnodai Hospital, National Center for Global Health and Medicine ( Site 8522)
Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)
PHASE2A cross-over, polysomnography study to test the safety, tolerability and ef...
Location
Multiple Locations
A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)
PHASE1This is a study to evaluate next-day residual effects of MK-4305 on highway...
Location
Merck Sharp & Dohme B.V.
A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)
PHASE3This study will establish the safety and tolerability of suvorexant (MK-430...
Location
Multiple Locations
Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)
PHASE3This study aims to examine the safety and efficacy of suvorexant (MK-4305) ...
Location
Multiple Locations